Ancora Advisors’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Ancora Advisors’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-43,040	Closed	-$425K	–	2349
2022 Q3	$425K	Hold	43,040	–	–	0.01%	529
2022 Q2	$421K	Buy	43,040 +3,000	+7%	+$29.5K	0.01%	565
2022 Q1	$392K	Buy	40,040 +10,000	+33%	+$97.6K	0.01%	608
2021 Q4	$294K	Buy	30,040 +7,747	+35%	+$75.6K	0.01%	697
2021 Q3	$217K	Hold	22,293	–	–	0.01%	769
2021 Q2	$216K	Buy	22,293 +11,537	+107%	+$112K	0.01%	742
2021 Q1	$104K	Buy	+10,756	New	+$104K	﹤0.01%	864

Ancora Advisors's SHAC Position: Q4 2022 in Review

Ancora Advisors sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 43,040 shares — an estimated $425K sold.

Ancora Advisors first reported a position in SHAC in Q1 2021 and held it in 7 quarters. The position peaked at $425K in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Ancora Advisors reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Ancora Advisors sold 43,040 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $425K.
Ancora Advisors first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q1 2021 and held it in 7 quarters.
Ancora Advisors's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $425K in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Ancora Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.